Showing results (1-10 of 768) with videos related to
Sort By:
Pageof 77
The Journal of Dermatological Treatment|October 28, 2003
Case studies in severe psoriasis: A clinical strategyMark Lebwohl, Alan Menter, John Koo, et al.Journal of the American Academy of Dermatology|February 28, 2004
Combination therapy to treat moderate to severe psoriasisMark Lebwohl, Alan Menter, John Koo, et al.Journal of Drugs in Dermatology : JDD|August 19, 2016
Aerosol Foam Formulation of Fixed Combination Calcipotriene Plus Betamethasone Dipropionate is Highly Efficacious in Patients With Psoriasis Vulgaris: Pooled Data From Three Randomized Controlled StudiesLinda Stein Gold, Mark Lebwohl, Alan Menter, et al.Skinmed|May 23, 2017
Fixed-Combination Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam Is Well Tolerated in Patients with Psoriasis Vulgaris: Pooled Data from Three Randomized Controlled StudiesAlan Menter, Linda Stein Gold, John Koo, et al.International Journal of Dermatology|July 9, 2002
A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasisMark Lebwohl, Daniel Sherer, Ken Washenik, et al.Journal of Drugs in Dermatology : JDD|April 7, 2022
Long-Term Skin Clearance With Brodalumab in Patients With Psoriasis and Inadequate Response to Prior BiologicsMark Lebwohl, Alan Menter, Edward Lain, et al.International Journal of Dermatology|April 17, 2008
Combining systemic retinoids with biologic agents for moderate to severe psoriasisElizabeth C A Smith, Christy Riddle, M Alan Menter, et al.Journal of the American Academy of Dermatology|October 3, 2006
A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomesJohn Koo, Robin R Blum, Mark LebwohlJournal of Drugs in Dermatology : JDD|December 2, 2025
More Than Skin Clearance: Connecting Brodalumab's Mechanism of Action to Patient Outcomes in PsoriasisJohn Koo, George Han, Mark Lebwohl, et al.Dermatology and Therapy|April 4, 2020
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available EvidenceJashin J Wu, Joseph F Merola, Steven R Feldman, et al.Pageof 77